Intrabody B1 targeting TDP-43 modulates neuroinflammatory and metabolic pathways in a preclinical ALS model
- DOI
- 10.1016/j.neurot.2026.e01032
- Published
- 2026-09
- Container
- Neurotherapeutics
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.neurot.2026.e01032,
title = {Intrabody B1 targeting TDP-43 modulates neuroinflammatory and metabolic pathways in a preclinical ALS model},
author = {Y. Al Ojaimi and A. Dupuis and M. Palla and D. Lanznaster and R. Hergesheimer and L. Galineau and S. Serriere and A.A. Chami and P. Martineau and T. Alouane and S. Marouillat and C. Dupuy and B.L. Schneider and C. Veyrat-Durebex and F. Masse and F. Trovero and C.R. Andres and P. Corcia and P. Vourcʼh and H. Blasco},
year = {2026},
journal = {Neurotherapeutics},
doi = {10.1016/j.neurot.2026.e01032},
url = {https://doi.org/10.1016/j.neurot.2026.e01032}
}RIS
TY - JOUR TI - Intrabody B1 targeting TDP-43 modulates neuroinflammatory and metabolic pathways in a preclinical ALS model AU - Y. Al Ojaimi AU - A. Dupuis AU - M. Palla AU - D. Lanznaster AU - R. Hergesheimer AU - L. Galineau AU - S. Serriere AU - A.A. Chami AU - P. Martineau AU - T. Alouane AU - S. Marouillat AU - C. Dupuy AU - B.L. Schneider AU - C. Veyrat-Durebex AU - F. Masse AU - F. Trovero AU - C.R. Andres AU - P. Corcia AU - P. Vourcʼh AU - H. Blasco PY - 2026 JO - Neurotherapeutics DO - 10.1016/j.neurot.2026.e01032 UR - https://doi.org/10.1016/j.neurot.2026.e01032 ER -
APA
Ojaimi, Y. A., Dupuis, A., Palla, M., Lanznaster, D., Hergesheimer, R., Galineau, L., Serriere, S., Chami, A., Martineau, P., Alouane, T., Marouillat, S., Dupuy, C., Schneider, B., Veyrat-Durebex, C., Masse, F., Trovero, F., Andres, C., Corcia, P., Vourcʼh, P., & Blasco, H. (2026). Intrabody B1 targeting TDP-43 modulates neuroinflammatory and metabolic pathways in a preclinical ALS model. Neurotherapeutics. https://doi.org/10.1016/j.neurot.2026.e01032
Source records
- crossref · retrieved 2026-09-27T04:04:49.531Z